HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nobuya Matsuoka Selected Research

FR 74366

1/2010The involvement of aldose reductase in alterations to neurotrophin receptors and neuronal cytoskeletal protein mRNA levels in the dorsal root ganglion of streptozotocin-induced diabetic rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nobuya Matsuoka Research Topics

Disease

12Brain Ischemia (Cerebral Ischemia)
02/2009 - 10/2002
10Hyperalgesia
06/2014 - 12/2008
10Stroke (Strokes)
02/2009 - 03/2003
10Ischemia
02/2009 - 10/2002
8Pain (Aches)
06/2015 - 11/2009
8Alzheimer Disease (Alzheimer's Disease)
04/2014 - 12/2005
6Diabetic Neuropathies (Diabetic Neuropathy)
04/2014 - 12/2008
5Parkinson Disease (Parkinson's Disease)
12/2008 - 06/2004
5Memory Disorders (Memory Loss)
11/2007 - 10/2002
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
03/2007 - 03/2004
5Brain Injuries (Brain Injury)
03/2007 - 12/2003
5Neurodegenerative Diseases (Neurodegenerative Disease)
03/2007 - 12/2003
5Dementia (Dementias)
12/2005 - 10/2002
4Neuralgia (Stump Neuralgia)
06/2015 - 01/2011
4Schizophrenia (Dementia Praecox)
10/2014 - 10/2004
4Catalepsy
10/2014 - 10/2004
4Brain Infarction
01/2005 - 10/2002
3Cognitive Dysfunction
10/2014 - 12/2005
3Cerebrovascular Disorders (Cerebrovascular Occlusion)
04/2014 - 11/2005
3Body Weight (Weight, Body)
04/2014 - 01/2011
3Hypoxia (Hypoxemia)
02/2007 - 01/2002
3Thrombosis (Thrombus)
01/2005 - 03/2004
2Wounds and Injuries (Trauma)
01/2016 - 09/2008
2Mental Disorders (Mental Disorder)
06/2012 - 04/2008
2Weight Gain
04/2011 - 01/2011
2Hyperphagia (Overeating)
04/2011 - 01/2011
2Hemorrhage
02/2009 - 11/2005
2Neuroblastoma
06/2007 - 01/2002
2Transient Ischemic Attack
05/2007 - 03/2003
2Infarction (Infarctions)
03/2007 - 10/2003
2Reperfusion Injury
02/2007 - 12/2003
2Ischemic Stroke
01/2005 - 03/2004
2Cerebral Infarction
01/2005 - 10/2003
2Neurologic Manifestations (Neurological Manifestations)
01/2005 - 10/2003
1Atopic Dermatitis (Atopic Eczema)
01/2021
1Dermatitis
01/2021
1Skin Diseases (Skin Disease)
01/2021
1Thrombophlebitis
11/2018
1Inflammation (Inflammations)
11/2018
1Burns
01/2016
1Arthritis (Polyarthritis)
06/2015
1Nociceptive Pain
06/2015

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
04/2014 - 10/2002
11Neuroprotective AgentsIBA
06/2007 - 03/2003
10Tacrolimus (Prograf)FDA LinkGeneric
02/2009 - 10/2002
7Analgesics (Analgesic Drugs)IBA
06/2015 - 09/2009
7LigandsIBA
06/2012 - 02/2005
5Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2015 - 11/2009
5Duloxetine Hydrochloride (Cymbalta)FDA Link
06/2015 - 05/2010
5Serotonin (5 Hydroxytryptamine)IBA
06/2015 - 11/2009
5Streptozocin (Streptozotocin)FDA Link
04/2014 - 12/2008
5((S)- 2- acetylamino- 3- ((R)- (1- (3- (piperidin- 4- yl)propionyl)piperidin- 3- ylcarbonyl))amino) propionic acid trihydrateIBA
11/2005 - 03/2004
4indeloxazineIBA
06/2015 - 03/2014
4Amyloid (Amyloid Fibrils)IBA
04/2014 - 07/2010
4FK1706IBA
06/2012 - 02/2005
4ImmunophilinsIBA
06/2012 - 02/2005
4Tissue Plasminogen Activator (Alteplase)FDA Link
02/2009 - 10/2002
4Scopolamine (Hyoscine)FDA Link
11/2007 - 10/2002
4N-(4-acetyl-1-piperazinyl) -4-fluorobenzamide monohydrateIBA
12/2005 - 10/2002
3Antipsychotic Agents (Antipsychotics)IBA
10/2014 - 10/2004
3Amitriptyline (Elavil)FDA LinkGeneric
06/2014 - 09/2009
3Antidepressive Agents (Antidepressants)IBA
06/2014 - 09/2009
3Glucose (Dextrose)FDA LinkGeneric
04/2014 - 12/2008
3Donepezil (Aricept)FDA LinkGeneric
03/2013 - 10/2002
3N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
06/2012 - 07/2002
3N-Methylaspartate (NMDA)IBA
06/2012 - 07/2002
3Adenosine (Adenocard)FDA LinkGeneric
12/2008 - 11/2007
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
12/2008 - 11/2007
35- (5- amino- 3- (4- fluorophenyl)pyrazin- 2- yl)- 1- isopropylprydine- 2(1H)- oneIBA
12/2008 - 11/2007
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
12/2008 - 06/2004
3Immunosuppressive Agents (Immunosuppressants)IBA
09/2008 - 06/2004
3Haloperidol (Haldol)FDA LinkGeneric
07/2008 - 10/2004
2Methamphetamine (Desoxyn)FDA LinkGeneric
10/2014 - 10/2004
2Dinoprostone (PGE2)FDA Link
06/2014 - 05/2010
2Serotonin and Noradrenaline Reuptake InhibitorsIBA
04/2014 - 05/2010
2Proteins (Proteins, Gene)FDA Link
03/2013 - 01/2002
2Olanzapine (Zyprexa)FDA Link
04/2011 - 01/2011
2TRPV1 receptorIBA
03/2011 - 01/2011
2Dihydrotachysterol (AT 10)IBA
03/2011 - 01/2011
2Protons (Proton)IBA
03/2011 - 01/2011
2Capsaicin (Zostrix)FDA Link
03/2011 - 01/2011
2N- (1- methyl- 2- oxo- 1,2,3,4- tetrahydro- 7- quinolyl)- 2- ((2- methylpyrrolidin- 1- yl)methyl)biphenyl- 4- carboxamideIBA
03/2011 - 01/2011
2Pregabalin (Lyrica)FDA Link
05/2010 - 09/2009
2Mexiletine (Mexitil)FDA LinkGeneric
05/2010 - 09/2009
2Sodium Channel BlockersIBA
05/2010 - 09/2009
2polyolIBA
01/2010 - 01/2009
2Dopamine (Intropin)FDA LinkGeneric
11/2009 - 11/2007
2Cytochromes c (Cytochrome c)IBA
09/2004 - 07/2004
2Poly (ADP-Ribose) Polymerase-1IBA
08/2004 - 06/2004
2QuinazolinonesIBA
08/2004 - 06/2004
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2004 - 12/2003
2Dizocilpine Maleate (Dizocilpine)IBA
04/2003 - 07/2002
1Histamine (Histamine Dihydrochloride)FDA Link
01/2021
1Ointments (Pastes)IBA
01/2021
1Semaphorin-3AIBA
01/2021
1Heparinoids (Heparinoid)IBA
11/2018
1BradykininIBA
06/2015

Therapy/Procedure

6Therapeutics
11/2018 - 10/2004
2Ligation
03/2011 - 01/2011
1Skin Care
01/2016